XAIR Beyond Air Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: XAIR

Price (delayed)

$0.4575

Market cap

$4.82M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$4.63

Enterprise value

$15.58M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 12

Beyond Air, Inc. is a clinical-stage medical device and biopharmaceutical company developing a revolutionary NO Generator and Delivery System, LungFit™, that uses NO generated from ambient air to deliver precise ...

Highlights
XAIR's gross profit has soared by 132% since the previous quarter and by 106% year-on-year
XAIR's revenue has surged by 129% year-on-year and by 19% since the previous quarter
The debt has soared by 100% since the previous quarter
Beyond Air's equity has shrunk by 54% YoY and by 36% QoQ
Sector: Healthcare
Industry: Medical Devices
Website: http://www.ait-pharm.com
Peers: OFIX

Key stats

What are the main financial stats of XAIR

XAIR stock price

How has the Beyond Air stock price performed over time
Intraday
3.55%
1 week
2.81%
1 month
-20.71%
1 year
-87.83%
YTD
-36.98%
QTD
-33.71%

Financial performance

How have Beyond Air's revenue and profit performed over time
Revenue
$6.92M
Gross profit
$126,000
Operating income
-$29.05M
Net income
-$31M
Gross margin
1.8%
Net margin
-447.7%
XAIR's gross profit has soared by 132% since the previous quarter and by 106% year-on-year
XAIR's revenue has surged by 129% year-on-year and by 19% since the previous quarter
The company's gross margin has surged by 127% QoQ and by 103% YoY
Beyond Air's operating margin has surged by 75% YoY and by 27% QoQ

Price vs fundamentals

How does XAIR's price correlate with its fundamentals

Growth

What is Beyond Air's growth rate over time

Valuation

What is Beyond Air stock price valuation
P/E
N/A
P/B
0.45
P/S
0.57
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.25
XAIR's EPS has surged by 78% year-on-year and by 31% since the previous quarter
The stock's price to book (P/B) is 84% less than its 5-year quarterly average of 2.8 and 66% less than its last 4 quarters average of 1.3
Beyond Air's equity has shrunk by 54% YoY and by 36% QoQ
XAIR's revenue has surged by 129% year-on-year and by 19% since the previous quarter
The price to sales (P/S) is 82% lower than the last 4 quarters average of 3.0

Efficiency

How efficient is Beyond Air business performance
XAIR's return on sales has surged by 75% year-on-year and by 31% since the previous quarter
The company's return on invested capital rose by 32% YoY and by 29% QoQ
XAIR's return on assets is up by 17% since the previous quarter and by 10% year-on-year
Beyond Air's ROE has decreased by 16% YoY and by 2.6% from the previous quarter

Dividends

What is XAIR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for XAIR.

Financial health

How did Beyond Air financials performed over time
The total assets is 29% more than the total liabilities
Beyond Air's total liabilities has surged by 81% YoY and by 59% QoQ
The company's quick ratio has surged by 75% YoY and by 42% QoQ
The debt is 191% greater than the equity
The debt has soared by 100% since the previous quarter
Beyond Air's equity has shrunk by 54% YoY and by 36% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.